When is raltegravir indicated in the treatment of pediatric HIV infection?

Updated: Nov 11, 2020
  • Author: Delia M Rivera, MD; Chief Editor: Russell W Steele, MD  more...
  • Print

An oral suspension formulation and chewable tablet of the integrase strand transfer inhibitor raltegravir are also available for pediatric patients aged 4 weeks and older who weigh at least 3 kg and less than 20 kg. [46, 47, 48] It may be take with or without food. This agent is used in combination with other HIV-1 antiretroviral agents.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!